Showing results (231-240 of 1,869) with videos related to

Sort By:
Pageof 187
Current Cancer Drug Targets|February 20, 2007
Indoleamine 2,3-dioxygenase in immune suppression and cancerAlexander J Muller, George C Prendergast
Current Cancer Drug Targets|February 20, 2007
T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunityJeurgen Foell, Becker Hewes, Robert S Mittler
Current Cancer Drug Targets|November 15, 2006
Protein kinases as drug targets in cancerMehmet Alper Arslan, Ozgur Kutuk, Huveyda Basaga
Current Cancer Drug Targets|November 11, 2008
The protein acetyltransferase ARD1: a novel cancer drug target?Thomas Arnesen, Paul R Thompson, Jan Erik Varhaug, et al.
Current Cancer Drug Targets|November 11, 2008
Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2Ulrich Wullner, Inga Neef, Andreas Eller, et al.
Current Cancer Drug Targets|November 27, 2013
Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunctionAdi Zheng, Hao Li, Xun Wang, et al.
Current Cancer Drug Targets|November 10, 2015
Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?Giandomenico Roviello, Daniele Generali
Current Cancer Drug Targets|November 10, 2015
Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast CancerNiladri Shekhar Dey, Biswajit Mukherjee, Ruma Maji, et al.
Current Cancer Drug Targets|April 8, 2010
A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapyShivani Rai Paliwal, Rishi Paliwal, Neeraj Mishra, et al.
Current Cancer Drug Targets|April 8, 2010
Human mesenchymal stem cells (hMSCs) as targets of DNA damaging agents in cancer therapySéverine Cruet-Hennequart, Aine M Prendergast, Frank P Barry, et al.
Pageof 187